Cyclerion Therapeutics (CYCN) Other Accumulated Expenses (2018 - 2019)
Cyclerion Therapeutics (CYCN) recorded quarterly Other Accumulated Expenses of $5.6 million in Q1 2019, down 43.3% quarter-over-quarter from $9.8 million in Q4 2018.
Cyclerion Therapeutics (CYCN) Other Accumulated Expenses (2018 - 2019) Analysis & Trends
Cyclerion Therapeutics' Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $5.6 million for Q1 2019.
- In Q1 2019, Other Accumulated Expenses changed N/A year-over-year to $5.6 million; the TTM figure through Mar 2019 stood at $5.6 million (changed N/A YoY), while the FY2018 annual figure was $9.8 million, changed N/A from the prior year.
- Other Accumulated Expenses was $5.6 million for Q1 2019 at Cyclerion Therapeutics, down from $9.8 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $9.8 million in Q4 2018 to a low of $5.6 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Cyclerion Therapeutics | 11.94 Mn | 8.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 5.56 Mn |
| Dec 31, 2018 | 9.80 Mn |